G protein-coupled receptor systems involved in cell growth and oncogenesis

Co-dependency of PKCδ and K-Ras: inverse association with cytotoxic drug sensitivity in KRAS mutant lung cancer.

Oncogene·2017

PTTG1 Levels Are Predictive of Saracatinib Sensitivity in Ovarian Cancer Cell Lines.

Clinical and translational science·2016

Adaptive reprogramming of the breast cancer kinome.

Clinical pharmacology and therapeutics·2014

A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop.

Oncogenesis·2013

Genes Induced by Reovirus Infection Have a Distinct Modular Cis-Regulatory Architecture.

Current genomics·2013

Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer.

Oncogene·2012

The evolution of new approaches to the treatment of congenital adrenal hyperplasia.

Endocrine reviews·2026

Digestive Hormones and Their Impact on Bariatric and Pharmacologic Weight-Loss Therapies.

Endocrine reviews·2026

Safeguarding the development of offspring: the role of genetic integrity of the maternal germline.

Endocrine reviews·2026

The metabolic roles of immune checkpoint molecules.

Endocrine reviews·2026

Single-Cell Landscapes of Adipose-Derived Mesenchymal Stem Cells: From Homeostatic Regulators to Obesity-Driven Central Hubs.

Endocrine reviews·2026

MASLD and the Cardiovascular-Kidney-Liver-Metabolic syndrome.

Endocrine reviews·2026

Silencing GJB2 attenuates IL-1β-induced chondrocyte injury by activating Nrf2/HO-1 signaling and preserving mitochondrial function.

Folia histochemica et cytobiologica·2026

DPM2 promotes melanoma progression and serves as a prognostic factor.

Melanoma research·2026

Efficacy of combined atorvastatin and paromomycin in treating experimental cryptosporidiosis in immunosuppressed mice.

QJM : monthly journal of the Association of Physicians·2026

Pan-RAS Inhibitor Shows Activity in Advanced Lung Cancer.

Cancer discovery·2026

Purine nucleoside phosphorylase in breast cancer from metabolic regulation to targeted therapy: challenges and opportunities.

RSC medicinal chemistry·2026

Yifeixiaoji decoction as an adjunct to osimertinib therapy in advanced EGFR-mutated NSCLC: protocol for a randomized, double-blind, placebo-controlled trial.

Frontiers in medicine·2026

Related Experiment Videos

G protein-coupled receptor systems involved in cell growth and oncogenesis

Related Concept Videos

Co-dependency of PKCδ and K-Ras: inverse association with cytotoxic drug sensitivity in KRAS mutant lung cancer.

PTTG1 Levels Are Predictive of Saracatinib Sensitivity in Ovarian Cancer Cell Lines.

Adaptive reprogramming of the breast cancer kinome.

A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop.

Genes Induced by Reovirus Infection Have a Distinct Modular Cis-Regulatory Architecture.

Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer.

The evolution of new approaches to the treatment of congenital adrenal hyperplasia.

Digestive Hormones and Their Impact on Bariatric and Pharmacologic Weight-Loss Therapies.

Safeguarding the development of offspring: the role of genetic integrity of the maternal germline.

The metabolic roles of immune checkpoint molecules.

Single-Cell Landscapes of Adipose-Derived Mesenchymal Stem Cells: From Homeostatic Regulators to Obesity-Driven Central Hubs.

MASLD and the Cardiovascular-Kidney-Liver-Metabolic syndrome.

Silencing GJB2 attenuates IL-1β-induced chondrocyte injury by activating Nrf2/HO-1 signaling and preserving mitochondrial function.

DPM2 promotes melanoma progression and serves as a prognostic factor.

Efficacy of combined atorvastatin and paromomycin in treating experimental cryptosporidiosis in immunosuppressed mice.

Pan-RAS Inhibitor Shows Activity in Advanced Lung Cancer.

Purine nucleoside phosphorylase in breast cancer from metabolic regulation to targeted therapy: challenges and opportunities.

Yifeixiaoji decoction as an adjunct to osimertinib therapy in advanced EGFR-mutated NSCLC: protocol for a randomized, double-blind, placebo-controlled trial.

Related Experiment Videos

G protein-coupled receptor systems involved in cell growth and oncogenesis

Related Concept Videos

Related Articles